Alphatec Holdings Inc. (NASDAQ: ATEC) reported a notable stock movement with a recent price at USD 14.02, up 0.57 or 4.24% in daily trading. This update matters for investors tracking the medical devices sector and for stakeholders observing market performance.
Company Overview
Founded in 1990 and headquartered in Carlsbad, California, Alphatec Holdings, Inc. is a US-based medical technology company specializing in spinal disorder surgical solutions. The firm designs and develops advanced systems for minimally invasive spinal treatment. Its product portfolio includes the SafeOp Neural InformatiX System for nerve injury risk reduction, the Sigma PTP access system, and multiple fixation platforms such as Invictus and Arsenal. The company also markets biologics and imaging products, and distributes through independent networks and direct sales channels across the United States.
Operating in the Medical – Devices industry within the Healthcare sector, Alphatec’s innovation-driven approach seeks to address both degenerative and deformity pathologies. The focus on intraoperative safety and precision systems reflects an aim to improve surgical outcomes.
Stock Performance
On the NASDAQ Global Select exchange, Alphatec trades under the symbol ATEC. As of the last session, the price closed at USD 14.02, reflecting a gain of USD 0.57. This movement represents a daily change of approximately 4.24%.
The trading range over the past 52 weeks has been between USD 4.88 and USD 16.70. This illustrates significant upward momentum since the lower end of the range, though volatility remains notable for investors considering entry or exit points.
Current trading volume registered at 2,026,116 shares, compared to an average volume of 2,196,190. Such activity signals investor interest and liquidity near historical norms, a consideration for both institutional and retail participants.
The company does not currently issue a dividend, reflecting a reinvestment strategy towards growth and expansion rather than shareholder payout.
Market Position and Sector
Within the Healthcare sector, Alphatec competes alongside major medical device manufacturers. Its market capitalization stands at approximately USD 2.07 billion, positioning it as a mid-cap company with growth potential. Stakeholder interest is supported by the firm’s focus on innovation in spine surgery solutions, a specialized yet growing field driven by demographic and technological factors.
Market position is reinforced by a comprehensive product suite covering complex spinal surgeries. The US-centered distribution network provides control and brand consistency, with potential avenues for international expansion if regulatory pathways are addressed.
Governance and Leadership
Leadership is headed by Chief Executive Officer Patrick S. Miles. Governance emphasizes integrating product development with clinical feedback, aiming to translate practitioner needs into viable surgical tools. Employee count is listed at 867 full-time staff, supporting operations from design to sales. The corporate address is 1950 Camino Vida Roble, Carlsbad, CA 92008, with direct contact available via phone at 760-431-9286.
Key Financial Data
- Price: USD 14.02
- Market Capitalization: USD 2,074,732,526
- Dividend: None
- 52-Week Range: USD 4.88 – 16.70
- Daily Change: +0.57 (4.24%)
- Volume: 2,026,116
- Average Volume: 2,196,190
- Exchange: NASDAQ Global Select
- ISIN: US02081G2012
- CUSIP: 02081G201
- IPO Date: 2006-06-12
For investors, these figures indicate liquidity, growth stage, and volatility characteristics. The absence of dividends places emphasis on capital appreciation potential.
FAQ
- Does Alphatec Holdings pay a dividend? No, the company does not currently pay a dividend.
- Where is Alphatec stock traded? Alphatec trades on the NASDAQ Global Select under the ticker ATEC.
- How many employees does the company have? The firm reports 867 full-time employees.
- What sector and industry classify Alphatec? Healthcare sector, Medical – Devices industry.
- When did Alphatec go public? The IPO date was June 12, 2006.
Conclusion
Alphatec Holdings shows an upward price move accompanied by consistent trading volumes and solid mid-cap market placement. With strong leadership and a focus on innovative spinal surgery technologies, the company remains of interest to growth-oriented investors. Monitoring sector trends and quarterly results will be essential for tracking future valuation changes.
Disclaimer
This article is for informational purposes only and does not constitute financial advice. Investors should conduct independent research before making investment decisions.
Announcement
For full information about the company, see the link below.